by GlobeNewsWire | Sep 14, 2016 | Globe Newswire
NEW YORK, Sept. 14, 2016 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental...
by GlobeNewsWire | Aug 11, 2016 | Globe Newswire
NEW YORK, Aug. 11, 2016 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental...
by GlobeNewsWire | Jul 29, 2016 | Globe Newswire
NEW YORK, July 29, 2016 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), confirms the information in the July 27, 2016 press release announcing positive results from the Phase 2a Alzheimer’s trial for ANAVEX 2-73. Dr....
by GlobeNewsWire | Mar 14, 2016 | Globe Newswire
NEW YORK, March 14, 2016 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative diseases including...
by GlobeNewsWire | Feb 19, 2016 | Globe Newswire
NEW YORK, Feb. 19, 2016 (GLOBE NEWSWIRE) — The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Anavex Life Sciences Corp. (NASDAQ:AVXL)...